A virus that shows no signs of disappearing, variants that are adept at dodging the body’s defenses, and waves of infections two, maybe three times a year — this may be the future of Covid-19, some scientists now […]
(ATLANTA, GA) – July 27, 2022 – PHASE Scientific Americas (PHASE Scientific), a high-growth biotech company, announced that it has donated 2,000 of its FDA EUA-approved INDICAID® COVID-19 Rapid Antigen At-Home Test (INDICAID® OTC) to Atlanta Public Schools for […]
(Garden Grove, CA) – July 8, 2022 – PHASE Scientific Americas (PHASE Scientific), a high-growth biotech company, announced that it has donated 4,300 of its approved INDICAID® COVID-19 Rapid Antigen At-Home Test (INDICAID® OTC) to […]
It may not always be clear when the kits will expire.
Americans were recently offered another chance to order free at-home coronavirus testing kits through the Postal Service. But since federal and state agencies have extended the shelf lives of several brands of tests, it may not always be clear when the free kits, […]
Packed indoor events and fully booked flights where masks are few and far between suggest that the pandemic is a distant, unpleasant memory.
In reality, Covid-19 cases have steadily increased nationwide since the end of March. […]
PHASE Scientific Americas (PHASE Scientific), a high-growth biotech company founded by bioengineers from UCLA, announces that it has donated 600 of its approved INDICAID® COVID-19 2-pack Rapid Antigen At-Home Test (INDICAID® OTC) to Stupid Cancer, Inc., a 501(c)3 nonprofit leader in the adolescent and young adult cancer movement for their […]
Updated May 24TH, 2022
Phase Scientific continuously monitors emerging variants of the virus that causes COVID-19 and how their mutations may impact the performance of the INDICAID® COVID-19 Rapid Antigen Test.
An independent evaluation by the National Institutes of Health (NIH) RADx Variant Task Force has determined that the INDICAID® […]
GARDEN GROVE, CA, April 25, 2022 — PHASE Scientific Americas (PHASE Scientific), a high-growth biotech company founded by bioengineers from UCLA, announces that its EUA approved INDICAID® COVID-19 Rapid Antigen At-Home Test (INDICAID® OTC) is now available for […]
April 04, 2022
Phase Scientific continuously monitors emerging variants of the virus that causes COVID-19 and how their mutations may impact the performance of the INDICAID® COVID-19 Rapid Antigen test. A sub-variant of Omicron designated BA.2 (B.1.1529.2) was detected in the U.S. in January 2022, and the Centers […]
Despite its pervasiveness and spikes in Asia and Europe, the Covid-19 Omicron BA.2—dubbed the Stealth Omicron by the World Health Organization (WHO)—has appeared to have lost its choke-hold on the U.S. “It’s stealthy no more,“ Carl Zimmer remarks in his New York Times piece.
Omicron BA.2 […]
